- Home
- DNN vs CVAC Comparison
DNN vs CVAC Comparison
Compare DNN & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- CVAC
- Stock Information
- Founded
- DNN 1954
- CVAC 2000
- Country
- DNN Canada
- CVAC Germany
- Employees
- DNN N/A
- CVAC N/A
- Industry
- DNN Other Metals and Minerals
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- DNN Basic Materials
- CVAC Health Care
- Exchange
- DNN Nasdaq
- CVAC Nasdaq
- Market Cap
- DNN 1.3B
- CVAC 1.2B
- IPO Year
- DNN 1997
- CVAC 2020
- Fundamental
- Price
- DNN $2.22
- CVAC $5.46
- Analyst Decision
- DNN Strong Buy
- CVAC Hold
- Analyst Count
- DNN 2
- CVAC 3
- Target Price
- DNN $3.00
- CVAC $6.83
- AVG Volume (30 Days)
- DNN 82.6M
- CVAC 882.1K
- Earning Date
- DNN 08-07-2025
- CVAC 08-14-2025
- Dividend Yield
- DNN N/A
- CVAC N/A
- EPS Growth
- DNN N/A
- CVAC N/A
- EPS
- DNN N/A
- CVAC 0.87
- Revenue
- DNN $3,176,679.00
- CVAC $566,039,775.00
- Revenue This Year
- DNN $288.69
- CVAC N/A
- Revenue Next Year
- DNN $22.40
- CVAC $24.04
- P/E Ratio
- DNN N/A
- CVAC $6.30
- Revenue Growth
- DNN 24.45
- CVAC 787.60
- 52 Week Low
- DNN $1.08
- CVAC $2.37
- 52 Week High
- DNN $2.47
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- DNN 70.00
- CVAC 61.24
- Support Level
- DNN $2.07
- CVAC $5.42
- Resistance Level
- DNN $2.28
- CVAC $5.48
- Average True Range (ATR)
- DNN 0.11
- CVAC 0.06
- MACD
- DNN 0.03
- CVAC -0.04
- Stochastic Oscillator
- DNN 89.34
- CVAC 61.54
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.